BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 23780687)

  • 21. Differential expression of hormonal and growth factor receptors in salivary duct carcinomas: biologic significance and potential role in therapeutic stratification of patients.
    Williams MD; Roberts D; Blumenschein GR; Temam S; Kies MS; Rosenthal DI; Weber RS; El-Naggar AK
    Am J Surg Pathol; 2007 Nov; 31(11):1645-52. PubMed ID: 18059220
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cervical lymph node metastasis in adenoid cystic carcinoma of the major salivary glands.
    INTERNATIONAL HEAD AND NECK SCIENTIFIC GROUP
    J Laryngol Otol; 2017 Feb; 131(2):96-105. PubMed ID: 27974071
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatocyte growth factor and c-Met immunoreactivity are associated with metastasis in high grade salivary gland carcinoma.
    Tsukinoki K; Yasuda M; Mori Y; Asano S; Naito H; Ota Y; Osamura RY; Watanabe Y
    Oncol Rep; 2004 Nov; 12(5):1017-21. PubMed ID: 15492787
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The epidermal growth factor receptor pathway in relation to pelvic lymph node metastasis and survival in early-stage cervical cancer.
    Eijsink JJ; Noordhuis MG; ten Hoor KA; Kok M; Hollema H; de Bock GH; Nijman HW; Schuuring E; Wisman GB; van der Zee AG
    Hum Pathol; 2010 Dec; 41(12):1735-41. PubMed ID: 21078436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of nodal metastasis in salivary gland cancer.
    Korkmaz H; Yoo GH; Du W; Hocwald E; Otero-Garcia JE; Volkan Adsay N; Shibuya T; Jacobs JR
    J Surg Oncol; 2002 Aug; 80(4):186-9. PubMed ID: 12210032
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tissue microarray-based studies of patients with lymph node negative breast carcinoma show that met expression is associated with worse outcome but is not correlated with epidermal growth factor family receptors.
    Tolgay Ocal I; Dolled-Filhart M; D'Aquila TG; Camp RL; Rimm DL
    Cancer; 2003 Apr; 97(8):1841-8. PubMed ID: 12673709
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic value of PSMA, c-MET and E-cadherin in salivary duct carcinoma.
    van Boxtel W; Uijen MJM; Verhaegh GW; Willems SM; Jonker MA; ; Schalken JA; van Engen-van Grunsven ICH; van Herpen CML
    Oral Oncol; 2020 Nov; 110():105018. PubMed ID: 33039794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human epidermal growth factor receptor 2 (HER2) in salivary gland carcinomas.
    Clauditz TS; Reiff M; Gravert L; Gnoss A; Tsourlakis MC; Münscher A; Sauter G; Bokemeyer C; Knecht R; Wilczak W
    Pathology; 2011 Aug; 43(5):459-64. PubMed ID: 21670724
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The implications of TrkA and MET aberrations in de novo salivary duct carcinoma.
    Ryu HJ; Koh YW; Yoon SO
    Hum Pathol; 2018 Nov; 81():18-25. PubMed ID: 29753009
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic value of lymph node density for major salivary gland carcinoma without clinical lymph node metastasis.
    Terada H; Suzuki H; Hanai N; Nishikawa D; Koide Y; Hasegawa Y
    Am J Otolaryngol; 2020; 41(1):102304. PubMed ID: 31727336
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clear cell myoepithelial carcinoma of salivary glands showing EWSR1 rearrangement: molecular analysis of 94 salivary gland carcinomas with prominent clear cell component.
    Skálová A; Weinreb I; Hyrcza M; Simpson RH; Laco J; Agaimy A; Vazmitel M; Majewska H; Vanecek T; Talarčik P; Manajlovic S; Losito SN; Šteiner P; Klimkova A; Michal M
    Am J Surg Pathol; 2015 Mar; 39(3):338-48. PubMed ID: 25581728
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overexpression of CMET is associated with signal transducer and activator of transcription 3 activation and diminished prognosis in oesophageal adenocarcinoma but not in squamous cell carcinoma.
    Mesteri I; Schoppmann SF; Preusser M; Birner P
    Eur J Cancer; 2014 May; 50(7):1354-60. PubMed ID: 24565853
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frequent PTEN loss and differential HER2/PI3K signaling pathway alterations in salivary duct carcinoma: Implications for targeted therapy.
    Saintigny P; Mitani Y; Pytynia KB; Ferrarotto R; Roberts DB; Weber RS; Kies MS; Maity SN; Lin SH; El-Naggar AK
    Cancer; 2018 Sep; 124(18):3693-3705. PubMed ID: 30289966
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunohistochemical study of c-erbB-2 oncoprotein overexpression in human major salivary gland carcinoma: an indicator of aggressiveness.
    Sugano S; Mukai K; Tsuda H; Hirohashi S; Furuya S; Shimosato Y; Ebihara S; Takeyama I
    Laryngoscope; 1992 Aug; 102(8):923-7. PubMed ID: 1353853
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Utility of 18F-FDG PET/CT for detecting neck metastasis in patients with salivary gland carcinomas: preoperative planning for necessity and extent of neck dissection.
    Kim MJ; Kim JS; Roh JL; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    Ann Surg Oncol; 2013 Mar; 20(3):899-905. PubMed ID: 23161114
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Value of anatomic site, histology and clinicopathological parameters for prediction of lymph node metastasis and overall survival in head and neck melanomas.
    Ettl T; Irga S; Müller S; Rohrmeier C; Reichert TE; Schreml S; Gosau M
    J Craniomaxillofac Surg; 2014 Jul; 42(5):e252-8. PubMed ID: 24216129
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk of Nodal Metastasis in Major Salivary Gland Adenoid Cystic Carcinoma.
    Megwalu UC; Sirjani D
    Otolaryngol Head Neck Surg; 2017 Apr; 156(4):660-664. PubMed ID: 28168897
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic implications of altered human epidermal growth factor receptors (HERs) in gastric carcinomas: HER2 and HER3 are predictors of poor outcome.
    Begnami MD; Fukuda E; Fregnani JH; Nonogaki S; Montagnini AL; da Costa WL; Soares FA
    J Clin Oncol; 2011 Aug; 29(22):3030-6. PubMed ID: 21709195
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of phosphatase and tensin homolog protein expression is an independent poor prognostic marker in lung adenocarcinoma.
    Yanagawa N; Leduc C; Kohler D; Saieg MA; John T; Sykes J; Yoshimoto M; Pintilie M; Squire J; Shepherd FA; Tsao MS
    J Thorac Oncol; 2012 Oct; 7(10):1513-21. PubMed ID: 22982652
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Salivary duct carcinoma: Clinicopathologic features, morphologic spectrum, and somatic mutations.
    Luk PP; Weston JD; Yu B; Selinger CI; Ekmejian R; Eviston TJ; Lum T; Gao K; Boyer M; O'Toole SA; Clark JR; Gupta R
    Head Neck; 2016 Apr; 38 Suppl 1():E1838-47. PubMed ID: 26699379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.